Purchase Order 75F40120P00141
Award Date 4/7/20
Potential Completion Date 4/9/25
Potential Value $148K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Jamaica, NY 11433, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $70,253.52 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Biomerieux Inc. for preventive maintenance of Vitek MS diagnostic equipment. The contract has an ultimate completion date of June 25, 2025 and does not utilize any set-aside designations. Biomerieux Inc., a global leader in in vitro diagnostics, is the prime contractor and the sole provider of this specialized diagnostic maintenance service for the FDA. The contract is part of Biomerieux's...
- This is a $235,020.16 firm fixed price purchase order awarded by the Defense Health Agency to Biomerieux Inc., a foreign-owned, for-profit manufacturer of diagnostic goods. The contract is for pathogenic bacteria cost per reportable, with a completion date of June 30, 2023. The original solicitation requested responses in the prescribed SF1449 format, with pricing on the provided contract line items. Biomerieux Inc. is a leading global provider of in vitro diagnostic solutions, including...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Biomerieux Inc. for $4,092.81 in laboratory supplies. The contract has an ultimate completion date of January 30, 2014 and does not involve any set-aside designations. Biomerieux Inc. is a global leader in in vitro diagnostics, specializing in microbiological testing solutions for medical, food safety, and industrial applications. Through this contract, the company is supplying the FDA with its...
- This is a federal purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Biomerieux Inc., a for-profit manufacturer of diagnostic equipment and laboratory technologies. The purpose of the $170,688.00 firm-fixed-price contract is to provide a service maintenance agreement for a Biomerieux bioinstrumentation system. The contract does not have a set-aside designation, indicating Biomerieux may be considered a sole-source provider of this specialized diagnostic...
- This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Biomerieux Inc., a global leader in in vitro diagnostics. The $242,002.88 contract is for a service and preventative maintenance agreement for Biomerieux's laboratory instruments. The contract does not have a set-aside designation. Biomerieux, through its Biomerieux, Inc. division, provides a range of clinical diagnostic equipment, reagents, and supplies to various federal agencies,...
- This firm-fixed-price purchase order, awarded by the Food and Drug Administration (FDA), provides a maintenance agreement for the FDA's VIDAS instrument used for the detection of Salmonella antigens in imported produce. The contract, valued at $103,151.92, was awarded to Biomerieux Inc., doing business as Vitek Systems Inc., on August 24, 2015, with a completion date of August 8, 2025. The award does not have a set-aside designation, indicating Biomerieux is likely considered a sole-source...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Biomerieux Inc., a foreign-owned, for-profit manufacturer of diagnostic products and equipment. The $446,122.62 contract is for the maintenance and servicing of the agency's VITEK MS & 2XL microbiology testing systems over a multi-year period ending February 28, 2023. Biomerieux is a leading provider of in vitro diagnostic solutions, including microbiology analyzers,...
- This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of its specialized clinical diagnostic equipment, reagents, and supplies. The $4,243.20 firm-fixed-price contract, awarded by the Food and Drug Administration (FDA), is a delivery order under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle. The contract has an ultimate completion date of September 23, 2024 and does not involve any set-aside designation....
- The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order contract to Biomerieux Inc., a division of Biomerieux, Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic solutions. The $56,625.00 contract is for a Bacterial Identification and Monitoring System to be delivered by June 29, 2025. Biomerieux is a global leader in microbiology testing and has provided numerous proprietary diagnostic platforms, reagents, and...
- This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Biomerieux Inc., a global leader in in vitro diagnostics and microbial testing solutions. The contract, valued at $75,002.47, is for the procurement of VITEK 2 COMPACT 60 W/PC COMPUTER (BFS) equipment and associated options. This award does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, has been a long-standing supplier of specialized diagnostic platforms and...